Abetalipoproteinemia

WikiDoc Resources for Abetalipoproteinemia
Articles
Most recent articles on Abetalipoproteinemia Most cited articles on Abetalipoproteinemia Review articles on Abetalipoproteinemia Articles on Abetalipoproteinemia in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Abetalipoproteinemia Images of Abetalipoproteinemia Photos of Abetalipoproteinemia Podcasts & MP3s on Abetalipoproteinemia Videos on Abetalipoproteinemia
Evidence Based Medicine
Cochrane Collaboration on Abetalipoproteinemia Bandolier on Abetalipoproteinemia TRIP on Abetalipoproteinemia
Clinical Trials
Ongoing Trials on Abetalipoproteinemia at Clinical Trials.gov Trial results on Abetalipoproteinemia Clinical Trials on Abetalipoproteinemia at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Abetalipoproteinemia NICE Guidance on Abetalipoproteinemia NHS PRODIGY Guidance FDA on Abetalipoproteinemia CDC on Abetalipoproteinemia
Books
Books on Abetalipoproteinemia
News
Abetalipoproteinemia in the news Be alerted to news on Abetalipoproteinemia News trends on Abetalipoproteinemia
Commentary
Blogs on Abetalipoproteinemia
Definitions
Definitions of Abetalipoproteinemia
Patient Resources / Community
Patient resources on Abetalipoproteinemia Discussion groups on Abetalipoproteinemia Patient Handouts on Abetalipoproteinemia Directions to Hospitals Treating Abetalipoproteinemia Risk calculators and risk factors for Abetalipoproteinemia
Healthcare Provider Resources
Symptoms of Abetalipoproteinemia Causes & Risk Factors for Abetalipoproteinemia Diagnostic studies for Abetalipoproteinemia Treatment of Abetalipoproteinemia
Continuing Medical Education (CME)
CME Programs on Abetalipoproteinemia
International
Abetalipoproteinemia en Espanol Abetalipoproteinemia en Francais
Business
Abetalipoproteinemia in the Marketplace Patents on Abetalipoproteinemia
Experimental / Informatics
List of terms related to Abetalipoproteinemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Synonyms and keywords: Acanthocytosis, Bassen-Kornzweig syndrome, apolipoprotein B deficiency, microsomal triglyceride transfer protein deficiency, MTP deficiency

Overview

Abetalipoproteinemia is a rare genetic disorder (autosomal recessive) that interferes with the normal absorption of fat and fat soluble vitamins from food. It is not to be confused with dysbetalipoproteinemia.

Features

Abetalipoproteinemia is an inherited disorder that affects the absorption of dietary fats, cholesterol, and certain vitamins. People affected by this disorder are not able to make certain lipoproteins, which are molecules that consist of proteins combined with cholesterol and particular fats called triglycerides. This leads to a multiple vitamin deficiency, affecting the fat soluble vitamin A, vitamin D, vitamin E, and vitamin K. However, many of the observed effects are due to vitamin E deficiency in particular.

The signs and symptoms of abetalipoproteinemia appear in the first few months of life. They can include failure to gain weight and grow at the expected rate (failure to thrive); diarrhea; abnormal star-shaped red blood cells (acanthocytosis); and fatty, foul-smelling stools (steatorrhea). Specifically the stool may contain large chunks of fat and or blood. Other features of this disorder may develop later in childhood and often impair the function of the nervous system. They can include poor muscle coordination, difficulty with balance and movement (ataxia), and progressive degeneration of the light-sensitive layer (retina) at the back of the eye that can progress to near-blindness. Adults in their thirties or forties may have increasing difficulty with balance and walking. Many of the signs and symptoms of abetalipoproteinemia result from a severe vitamin deficiency, especially vitamin E deficiency which typically results in eye problems with degeneration of the spinocerebellar and dorsal columns tracts.

Diagnosis

The inability to absorb fat in the ileum will result in steatorrhea, or fat in the stool. As a result, this can be clinically diagnosed when foul smelling stool is encountered. Low plasma chylomicron levels are also characteristic. Acanthocytes are seen on blood smear.

Pathology

Acanthocytes (Abetalipoproteinemia)

Pathophysiology

Two genes have been identified in which mutations are associated with this disorder: microsomal triglyceride transfer protein (MTTP) and apolipoprotein B (ApoB).

The MTTP gene provides instructions for making a protein called microsomal triglyceride transfer protein, which is essential for creating beta-lipoproteins. These lipoproteins are necessary for the absorption of fats, cholesterol, and fat-soluble vitamins from the diet and the efficient transport of these substances in the bloodstream. Most of the mutations in this gene lead to the production of an abnormally short microsomal triglyceride transfer protein, which prevents the normal creation of beta-lipoproteins in the body. MTTP associated mutations are inherited in an autosomal recessive pattern, which means both copies of the gene must be faulty to produce the disease.

There is an absence of apolipoprotein B. On intestinal biopsy, vacuoles containing lipids are seen in enterocytes. Since there is no or little assimilation of chylomicrons, their levels in plasma remains low. This disorder may also result in fat accumulation in the liver (hepatic steatosis). Because the epithelial cells of the bowel lack the ability to place fats into chylomicrons, lipids accumulate at the surface of the cell, crowding the functions that are necessary for proper absorption.

Treatment

Treatment with Vitamin E is recommended. Dietary restriction of triglycerides has also been useful.

References

• Abetalipoproteinemia at NLM Genetics Home Reference